X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/26/2852721/35575/en/Aptose-Reports-Results-for-the-Fourth-Quarter-and-Full-Year-2023.html
https://www.globenewswire.com/news-release/2024/03/18/2848185/35575/en/Aptose-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provide-Corporate-Update-on-Tuesday-March-26-2024.html
https://www.globenewswire.com/news-release/2024/03/18/2848185/35575/en/Aptose-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provide-Corporate-Update-on-Tuesday-March-26-2024.html
https://www.globenewswire.com/news-release/2024/01/31/2821542/35575/en/Aptose-Announces-Closing-of-9-7-Million-Public-Offering-and-Concurrent-4-Million-Private-Placement-with-Hanmi-Pharmaceutical-Including-Full-Exercise-of-Over-Allotment-Option.html
https://www.globenewswire.com//news-release/2024/01/26/2817923/35575/en/Aptose-Announces-Pricing-of-8-4-Million-Public-Offering-and-a-Concurrent-4-Million-Private-Placement-with-Hanmi-Pharmaceutical.html
https://www.globenewswire.com//news-release/2023/12/09/2793449/35575/en/Aptose-Tuspetinib-Clinical-Data-Featured-in-Oral-Presentation-at-the-2023-ASH-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/11/30/2789005/35575/en/Aptose-Appoints-Fletcher-Payne-Chief-Business-Officer-Expanding-his-Executive-Role.html
https://www.globenewswire.com//news-release/2023/11/09/2777755/35575/en/Aptose-Reports-Results-for-the-Third-Quarter-2023.html
https://www.globenewswire.com//news-release/2023/11/02/2772405/35575/en/Aptose-Tuspetinib-Clinical-Data-Selected-for-Oral-Presentation-at-the-2023-ASH-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/10/30/2769327/35575/en/Aptose-Presents-Highlights-from-Clinical-Update-Webcast-Featuring-Latest-Available-Data-on-AML-Drug-Tuspetinib.html
Market Place
Share 
